Adam K. Stern

Insider Reports History

Reporting-owner location: New York, NY
Latest reporting-owner signature: /s/ Norman Staskey, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Adam K. Stern

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 743,785
Estimated value: $357,016
Report date: 10 Jul 2026
Price: $0.4800
Ownership: Through SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 416,900
Estimated value: $200,112
Report date: 10 Jul 2026
Price: $0.4800
Ownership: Through A.K.S Family Partners LP

Form 4 holding Director

VivoSim Labs, INC.

Security class: Common Stock
Shares / value: 19,899
Estimated value: $37,921
Report date: 27 Jan 2026
Price: $1.91
Ownership: Direct

Form 4 holding Director

DarioHealth Corp.

Security class: Common Stock
Shares / value: 29,717
Estimated value: $16,047
Report date: 11 Sep 2025
Price: $0.5400
Ownership: Direct

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 28,260
Estimated value: $13,564
Report date: 16 Oct 2025
Price: $0.4800
Ownership: Direct

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 26,500
Estimated value: $12,720
Report date: 16 Oct 2025
Price: $0.4800
Ownership: Through AKS Family Foundation

Form 4 holding Director

DarioHealth Corp.

Security class: Common Stock
Shares / value: 6,146
Estimated value: $3,318
Report date: 11 Sep 2025
Price: $0.5400
Ownership: By AKS Family Partners L.P.

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 6,000
Estimated value: $2,880
Report date: 16 Oct 2025
Price: $0.4800
Ownership: Through Pavillion Capital Partners LLC

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 6,000
Estimated value: $2,880
Report date: 16 Oct 2025
Price: $0.4800
Ownership: Through Piper Venture Partners LLC

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 3,000
Estimated value: $1,440
Report date: 16 Oct 2025
Price: $0.4800
Ownership: Through Stern Aegis Ventures LLC 401k Plan for the Benefit of Adam K Stern

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 1,000
Estimated value: $480
Report date: 16 Oct 2025
Price: $0.4800
Ownership: Through IRA Adam K Stern - Rollover IRA

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Warrants to Purchase Common Stock
Shares / value: 630,335
Estimated value
Report date: 10 Jul 2026
Price
Ownership: Through SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Warrants to Purchase Common Stock
Shares / value: 344,710
Estimated value
Report date: 10 Jul 2026
Price
Ownership: Through A.K.S Family Partners LP
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Common Stock
Shares / value: 210,687
Estimated value
Report date: 13 Feb 2025
Price
Ownership: Indirect

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Warrants to Purchase Common Stock
Shares / value: 141,462
Estimated value
Report date: 10 Jul 2026
Price
Ownership: Direct
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount

Form 4 holding Director

DarioHealth Corp.

Security class: Series-C Preferred Stock
Shares / value: 123,763
Estimated value
Report date: 07 Jan 2025
Price
Ownership: AKS Family Partners L.P.

Form 4 holding Director

DarioHealth Corp.

Security class: Series-C Preferred Stock
Shares / value: 123,763
Estimated value
Report date: 11 Sep 2025
Price
Ownership: By AKS Family Partners L.P.

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Series C Convertible Preferred Stock
Shares / value: 265
Estimated value
Report date: 16 Oct 2025
Price
Ownership: Through SternAegis Ventures, LLC Defined Benefit Plan for the Benefit of Adam K Stern
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount

Form 4 holding 10%+ Owner

Matinas BioPharma Holdings, Inc.

Security class: Series C Convertible Preferred Stock
Shares / value: 101
Estimated value
Report date: 16 Oct 2025
Price
Ownership: Through AKS Family Partners
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount

Form 4 holding Director

DarioHealth Corp.

Security class: Series D-2 Preferred Stock
Shares / value: 0
Estimated value
Report date: 07 Jan 2025
Price
Ownership: AKS Family Partners L.P.
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Adam K. Stern

4 VIVS

VivoSim Labs, INC.

Report period: 27 Jan 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Jan 2026, 19:47
Role: Director
Next action: Open filing details

4 MTNB

Matinas BioPharma Holdings, Inc.

Report period: 16 Oct 2025
Transactions: 11
Transaction value: $0
Accepted by SEC: 13 Aug 2026, 16:04
Role: 10%+ Owner
Next action: Open filing details

4 DRIO

DarioHealth Corp.

Report period: 11 Sep 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Sep 2025, 18:03
Role: Director
Next action: Open filing details

3 MTNB

Matinas BioPharma Holdings, Inc.

Report period: 13 Feb 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 10 Apr 2025, 21:39
Role: 10%+ Owner
Next action: Open filing details

4 DRIO

DarioHealth Corp.

Report period: 07 Jan 2025
Transactions: 1
Transaction value: +$100,000
Accepted by SEC: 10 Jan 2025, 16:04
Role: Director
Next action: Open filing details

4 VIVS

ORGANOVO HOLDINGS, INC.

Report period: 07 Aug 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 09 Aug 2024, 16:01
Role: Director
Next action: Open filing details

4 DRIO

DarioHealth Corp.

Report period: 06 Mar 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 08 Mar 2024, 16:15
Role: Director
Next action: Open filing details

4 DRIO

DarioHealth Corp.

Report period: 15 Feb 2024
Transactions: 1
Transaction value: +$250,000
Accepted by SEC: 01 Mar 2024, 16:01
Role: Director
Next action: Open filing details

4 VIVS

ORGANOVO HOLDINGS, INC.

Report period: 17 Nov 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Nov 2023, 18:43
Role: Director
Next action: Open filing details

4 VIVS

ORGANOVO HOLDINGS, INC.

Report period: 10 Nov 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Nov 2022, 20:12
Role: Director
Next action: Open filing details

4 DRIO

DarioHealth Corp.

Report period: 18 May 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 20 May 2022, 17:00
Role: Director
Next action: Open filing details

3 CYCU

Western Acquisition Ventures Corp.

Report period: 11 Jan 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 11 Jan 2022, 16:39
Role: Director
Next action: Open filing details

4 VIVS

ORGANOVO HOLDINGS, INC.

Report period: 07 Oct 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Oct 2021, 18:00
Role: Director
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Adam K. Stern

Insider Reports Filed by Adam K. Stern